Export 12 results:
Sort by: Author Title Type [ Year  (Desc)]
Aboulghar, M., "Ethnicity affects IVF outcome world-wide with no clear explanation.", BJOG : an international journal of obstetrics and gynaecology, 2016 Oct 03.
, "The influence of social factors on gender health.", Human reproduction (Oxford, England), vol. 31, issue 8, pp. 1631-7, 2016 Aug. Abstract

Male births exceed female births by 5-6% (for a sex ratio at birth of 1.05-1.06) while a women's life expectancy, on a global scale, is about 6 years longer. Thus within various age groups the male:female ratio changes over time. Until age 50 years men outnumber women; thereafter their numbers show a sharp decline. Consequently at age 80 years, there are many more women than men. An estimated 25% of this male excess mortality is due to biological causes, the rest being explained by behavioural, cultural and environmental factors. For both women and men, the main health risks related to lifestyle are smoking, alcohol, unhealthy diet and physical inactivity. In the year 2010, overweight (BMI: 25-29 kg/m(2)) and obesity (BMI: >30 kg/m(2)) were responsible for over 3 million deaths, with similar relative risks in men and women for overweight and obesity. Smoking and alcohol are the major causes of the global gender gap in mortality. For women in some parts of the world however pregnancy is also hazardous. On a global scale, in 2013 about 300 000 deaths were related to pregnancy, with sub-Saharan Africa registering the highest maternal mortality: over 500 maternal deaths per 100 000 births. Additional woman's health risks arise from gender discrimination, including sex-selective abortion, violence against women and early child marriage. Providers should be aware of the effect that these risks can have on both reproductive and general health.

Aboulghar, M., H. Marie, A. Y, M. Aboulghar, A. Nasr, G. Serour, and R. Mansour, "GnRH agonist plus vaginal progesterone for luteal phase support in ICSI cycles: a randomized study", Reproductive Biomedicine online, vol. 30, issue 1, pp. 52-56, 2015. agonist_for_lps.pdf
M, A., S. W, A. Y, M. Aboulghar, G. Serour, and R. Mansour, "Impact of antimüllerian hormone assays on the outcomes of in vitro fertilization: a prospective controlled study.", Fertility and Sterility, vol. 101, issue 1, pp. 134-137, 2014.
Aboulghar, M., "Agonist and Antagonist Coast", Fertility and Sterility, vol. 97, issue 2, pp. 523-526, 2012.
Aboulghar, M., M. Aboulghar, A. Y, A. L. I. H, R. Mansour, and G. Serour, "The use of vaginal natural progesterone for prevention of preterm birth in IVF/ICSI pregnancies.", Reproductive Biomedicine Online, vol. 25, issue 12, pp. 133-138, 2012.
Aboulghar, M., "Barriers to conducting clinical research in reproductive medicine: Egypt", Fertility and Sterility, vol. 96, issue 4, pp. 805-806, 2011.
Mansour, R., G. Serour, M. Aboulghar, O. Kamal, and H. Al-Inany, "The impact of vanishing fetuses on the outcome of ICSI pregnancies.", Fertility and sterility, vol. 94, issue 6, pp. 2430-2, 2010 Nov. Abstract

Vanishing fetal twins occurred in 9% (264 out of 2,829) intracytoplasmic sperm injection pregnancies and are associated with a lower fetal loss rate in the first trimester. The live birth rate was higher in pregnancies associated with vanishing fetuses.

Aboulghar, M., waleed saber, Y. Amin, M. Aboulghar, R. Mansour, and G. Serour, "Prospective, randomized study comparing highly purified urinary follicle-stimulating hormone (FSH) and recombinant FSH for in vitro fertilization/intracytoplasmic sperm injection in patients with polycystic ovary syndrome.", Fertility and sterility, vol. 94, issue 6, pp. 2332-4, 2010 Nov. Abstract

In a randomized study comparing purified urinary FSH with recombinant FSH for IVF/intracytoplasmic sperm injection in patients with polycystic ovary syndrome, there was no significant difference between the mean total dose of FSH used, duration of stimulation, number of retrieved oocytes, number of mature oocytes, number of embryos transferred, or the ongoing pregnancy rate between the two groups. However, there were significantly more fertilized oocytes, a higher fertilization rate, more top-quality embryos, and more cryopreserved embryos in the urinary FSH group.

Aboulghar, M., "Treatment of ovarian hyperstimulation syndrome.", Seminars in reproductive medicine, vol. 28, issue 6, pp. 532-9, 2010 Nov. Abstract

Mild forms of ovarian hyperstimulation syndrome (OHSS) do not require treatment. Moderate OHSS should be followed up on an outpatient basis with no specific treatment. Severe OHSS requires proper evaluation. Investigations are done to evaluate hematocrit, electrolytes, and kidney and liver function. Conservative treatment with intravenous (i.v.) fluids and close monitoring is usually done. Intensive care admission is indicated in cases with severe respiratory distress or major electrolyte imbalance with elevated serum creatinine. Crystalloids in the form of i.v. saline and colloids as albumin or hydroxyethyl starch are commonly used to expand intravascular volume. Dopamine can be used to improve diuresis, and prophylactic heparin is administered to prevent venous thrombosis. Diuretics are generally contraindicated because they may further contract intravascular volume. Abdominal or vaginal aspiration of ascitic fluid results in marked improvement of symptoms, improved diuresis, and shortened hospital stay. The current trend to treat patients with i.v. fluids, albumin, and to perform aspiration of ascitic fluid on an outpatient basis has been found to be a more cost-effective protocol of treatment.

Aboulghar, M., and B. Rizk, Ovarian Stimulation, , London, Cambridge University Press, 2010.